UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 14, 2004
------------------
Ibis Technology Corporation
---------------------------
(Exact name of registrant as specified in its charter)
Massachusetts 0-23150 04-2987600
- ------------- ------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
32 Cherry Hill Drive, Danvers, Massachusetts 01923
- -----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
----------------
ITEM 8.01 OTHER EVENTS
On September 14, 2004, Ibis Technology Corporation announced final customer
acceptance of the Ibis i2000 oxygen implanter that was ordered by a leading
silicon wafer manufacturer in February of this year and shipped in May. A copy
of the press release is being furnished as Exhibit 99.1 attached hereto. This
information shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
---------------------------
Date: September 14, 2004 /s/ William J. Schmidt
------------------------------------------
William J. Schmidt Chief Financial Officer
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
99.1 Press Release Announcing Final Acceptance of the Ibis
i2000 oxygen implanter.